Complications of injectable fillers and neurotoxins

被引:49
作者
Cox, Sue Ellen [1 ]
Adigun, Chris G. [2 ]
机构
[1] Aesthet Solut, Chapel Hill, NC 27517 USA
[2] NYU, Dept Dermatol, Chapel Hill, NC USA
关键词
botulinum toxin; complications; injectables; SOFT-TISSUE FILLER; HYALURONIC-ACID; DERMAL FILLERS; DOUBLE-BLIND; INJECTION; EFFICACY; NECROSIS; SAFETY; MANAGEMENT; AUGMENTATION;
D O I
10.1111/j.1529-8019.2012.01455.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
All cosmetic injectable products are associated with the risk of both early and delayed complications. Early and expected side effects include swelling, bruising, and erythema at the injection. It is of utmost importance that patients are educated on the treatment they are consenting to receive and the potential risk of these therapies. Side effects of the various cosmetic injectable products, including both injectable neurotoxins and soft tissue fillers, are often technique associated, such as placing the filler too superficial or unintentional paralysis of facial muscles. Other complications, such as necrosis, intravascular injections, and infection may not be entirely technique-dependent, and must be managed swiftly and effectively. Finally, immunologic phenomena, such as delayed-type hypersensitivity reactions and foreign body granulomas, are complications that have no relationship to technique, and thus proper counseling and knowledge of management is required.
引用
收藏
页码:524 / 536
页数:13
相关论文
共 38 条
[1]
Severe, intractable headache after injection with botulinum A exotoxin: Report of 5 cases [J].
Alam, M ;
Arndt, KA ;
Dover, JS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (01) :62-65
[2]
Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature [J].
Alijotas-Reig, J. ;
Garda-Gimenez, V. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (02) :150-161
[3]
[Anonymous], 2010, 2000 2008 2009 NAT P
[4]
Adverse event reporting for botulinum toxin type A [J].
Batra, RS ;
Dover, JS ;
Arndt, KA .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (06) :1080-1082
[5]
NewFill for skin augmentation: A new filler or failure? [J].
Beljaards, RC ;
De Roos, KP ;
Bruins, FG .
DERMATOLOGIC SURGERY, 2005, 31 (07) :772-776
[6]
Injectable poly-L-lactic acid for cosmetic enhancement: Learning from the European experience [J].
Butterwick, Kimberly ;
Lowe, Nicholas J. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 61 (02) :281-293
[7]
Polymethylmethacrylate microspheres/collagen as a tissue augmenting agent: Personal experience over 5 years [J].
Carruthers, A ;
Carruthers, JDA .
DERMATOLOGIC SURGERY, 2005, 31 (11) :1561-1565
[8]
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines [J].
Carruthers, JA ;
Lowe, NJ ;
Menter, MA ;
Gibson, J ;
Nordquist, M ;
Mordaunt, J ;
Walker, P ;
Eadie, N .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (06) :840-849
[9]
Understanding, avoiding, and managing dermal filler complications [J].
Cohen, Joel L. .
DERMATOLOGIC SURGERY, 2008, 34 (01) :S92-S99
[10]
Five-year safety and efficacy of a novel polymethylmethacrylate aesthetic soft tissue filler for the correction of nasolabial folds [J].
Cohen, Steven R. ;
Berner, Carl F. ;
Busso, Mariano ;
Clopton, Paul ;
Hamilton, Douglas ;
Romano, James J. ;
Rullan, Peter P. ;
Thaler, Millard P. ;
Ubogy, Zeena ;
Vecchione, Thomas R. .
DERMATOLOGIC SURGERY, 2007, 33 (02) :S222-S230